Former Florida congressman Dave Weldon is President-elect Donald Trump’s pick to lead the CDC, giving Robert F. Kennedy Jr. a ...

Eli Lilly and Novo Nordisk have filed dozens of lawsuits against compounding pharmacies marketing their own versions of ...

The Senate Judiciary Committee narrowly advanced a bill Thursday that would change the way the Patent Trial and Appeal Board ...

Sanofi is proposing a new model for distributing drug discounts under the federal 340B program, according to the Wall Street ...

As the healthcare priorities of President-elect Donald Trump and his HHS pick Robert F. Kennedy Jr. take shape, one idea ...

Aizen Ther­a­peu­tics has left stealth with $13 mil­lion in seed fund­ing and a mis­sion to ad­vance “mir­ror pep­tide” drug ...

Novartis is acquiring Kate Therapeutics for $1.1 billion, focusing on gene therapy and neuroscience. CEO Vas Narasimhan and ...

The Jefferies London Healthcare Conference at Waldorf Hilton drew thousands, focusing heavily on GLP-1 manufacturing. Notable ...

Jazz Pharmaceuticals earned an FDA approval on Wednesday for zanidatamab, the HER2-targeted bispecific antibody it picked up ...

Halozyme Therapeutics said Friday that it has pulled its proposal to buy Evotec, a struggling German biotech that Halozyme said was ...

Lexicon Pharmaceuticals is reverting to a clinical development company after facing repeated setbacks at the FDA for its type 1 diabetes and chronic kidney disease drug.

Novartis’ reorganization is paying off, CEO Vas Narasimhan told investors at an event Thursday in London. The company raised ...